Table 4.
Oncological outcomes, median [IQR], and % (n).
| Outcomes | LOCRC | EOCRC | p |
|---|---|---|---|
| Number of patients | 1650 | 423 | |
| Metachronous CRC tumors | 2% (33) | 0.2% (1) | 0.073 |
| Other neoplasms | 19% (314) | 4% (55) | <0.0001 |
| Adjuvant therapy | 48% (792) | 73% (309) | <0.0001 |
| Follow-up, months | 27 [7–60] | 28 [9–61] | 0.948 |
| Death | 12% (198) | 22% (93) | <0.0001 |
| Cancer-specific death | 8% (132) | 22% (93) | <0.0001 |
| Recurrence or progression | 21% (346) | 40% (169) | <0.0001 |
Abbreviations: IQR, interquartile range; LOCRC, late-onset colorectal cancer; EOCRC, early-onset colorectal cancer; CRC, colorectal cancer. Continuous data are analyzed with unpaired two-sided T- or Mann–Whitney tests; dichotomous and categorical data are analyzed with Pearson’s χ2-test and Fisher’s exact test.